Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine and Irinotecan in Bladder Cancer
NCT00089128Phase 2Terminated
- Sponsor
- Medical University of South Carolina
- Start
- Nov 2001
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of irinotecan in bladder cancer, sponsored by Medical University of South Carolina. Started Nov 2001; status: terminated.
02
Drugs
irinotecan
03
Conditions
bladder cancer
Beyond the preview
Go deeper on NCT00089128.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00089128.